Cryoablation for atrial fibrillation maintains sinus rhythm in ~70-80% of patients after a first procedure, showing no significant efficacy differences compared to radiofrequency ablation.
Does cryoablation improve efficacy and safety compared to radiofrequency ablation in patients with atrial fibrillation?
Cryoablation and radiofrequency ablation have similar efficacy for maintaining sinus rhythm in atrial fibrillation, but differ in their safety profiles, with cryoablation having less pericardial effusion but more phrenic nerve damage.
Pulmonary vein isolation is the standard for atrial fibrillation ablation. Although the most commonly applied energy source is radiofrequency (RF), cryoablation has rapidly evolved as a powerful one-shot tool, particularly after the introduction of the second-generation catheter, gaining widespread use in recent years. The efficacy in maintaining sinus rhythm after a first ablative procedure is ∼70-80%, and the randomization studies comparing cryoablation to RF have not been able to reveal significant differences up to now. Although different baseline characteristics may influence the efficacy of cryoablation, we are not yet able to distinguish which patients may benefit from a personalized choice of ablative source. Regarding safety, cryoballoon ablation appears to be associated with a lower rate of pericardial effusion and cardiac tamponade, mainly due to the lack of risk of overheating. The other side of the coin is a higher incidence of phrenic nerve damage, which occurs in 1-2% of procedures. In conclusion, we do not yet have definitive data to affirm the superiority of the RF technique over that of cryoablation. The choice of energy source currently depends on the availability of the centre and on the experience of the operator.
Penela et al. (Fri,) conducted a review in Atrial fibrillation. Cryoablation vs. Radiofrequency (RF) ablation was evaluated on Maintaining sinus rhythm after a first ablative procedure. Cryoablation for atrial fibrillation maintains sinus rhythm in ~70-80% of patients after a first procedure, showing no significant efficacy differences compared to radiofrequency ablation.